Singapore Reinforces Position as a Global Site for Pharma & Biotech; Biomedical Manufacturing Output Quadruples to Reach US$17 Billion

Earthtimes.org
18 Jun 2008

SAN DIEGO, June 18 /Xinhua-PRNewswire/ -- Singapore has firmly established
itself as a leading manufacturing hub in Asia with its strong track record,
sophisticated infrastructure, superior IP protection and reliability. Its
biomedical sciences manufacturing output expanded four-fold from US$4.4
billion in 2000 to US$17 billion in 2007 at a compounded annual growth rate of
21%, far surpassing the industry's global growth rate.

>>>> More